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NOS(NO2−) has recently emerged as an endocrine storage form of nitric oxide (NO)
and a signalling molecule that mediates a number of biological responses. Although the role of NO in
regulating cardiac function has been investigated in depth, the physiological signalling effects of nitrite on
cardiac function have only recently been explored. We now show that remarkably low concentrations of
nitrite (1 nM) signiﬁcantly modulate cardiac contractility in isolated and perfused Langendorff rat heart. In
particular, nitrite exhibits potent negative inotropic and lusitropic activities as evidenced by a decrease in left
ventricular pressure and relaxation, respectively. Furthermore, we demonstrate that the nitrite-dependent
effects are mediated by NO formation but independent of NO synthase (NOS) activity. Speciﬁcally, nitrite
infusion in the Langendorff system produces NO and cGMP/PKG-dependent negative inotropism, as
evidenced by the formation of cellular iron–nitrosyl complexes and inhibition of biological effect by NO
scavengers and by PKG inhibitors. These data are consistent with the hypothesis that nitrite represents an
eNOS-independent source of NO in the heart which modulates cardiac contractility through the NO–cGMP/
PKG pathway. The observed high potency of nitrite supports a physiological function of nitrite as a source of
cardiomyocyte NO and a fundamental signalling molecule in the heart.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionIt has been proposed that the circulating anion nitrite (NO2−) may
represent the largest physiological reservoir of nitric oxide (NO) in the
body [1]. Nitrite, present in mammalian blood at high nanomolar
concentrations, can be reduced to bioactive NO along a physiological
oxygen and pH gradient non-enzymatically by acidic disproportiona-
tion [2,3] or by a number of enzymes including xanthine oxidor-
eductase [4], nitric oxide synthase [5], mitochondrial cytochromes [6]
and deoxygenated haemoglobin andmyoglobin [7–9,21,22]. A number
of studies now show that nitrite mediates various biological responses
including hypoxic vasodilation [1,10], inhibition of mitochondrial
respiration [8,10], cytoprotection following ischemia/reperfusion [11–
14], and regulation of protein and gene expression [15]. While most ofted at Pulmonary and Vascular
titute, Critical Care Medicine
lth Building 10-CRC, Room 5-
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, University of Calabria, 87030
2906.
), tota@unical.it (B. Tota).
ll rights reserved.these effects are thought to be dependent on the reduction of nitrite to
NO, it has been suggested that nitrite may also mediate effects
independent of NO generation [15].
NO is an important paracrinemediator of cardiovascular signalling,
with low concentrations modulating a number of vascular responses.
In regards to cardiac contractility, both positive and negative inotropic
effects of NO have been observed, depending on preparation of the
model system and the type and dose of NO donor being used [16–19].
Given these effects of NO on cardiac function and the hypoxic
environment of the heart [20], we sought to determine whether
nitrite could act as an endocrine store of NO that modulates cardiac
mechanical performance. We recently reported that deoxygenated
cardiac myoglobin can reduce nitrite to NO via heme-based nitrite
reductase chemistry [21]. This reaction produces NO under hypoxic
and anaerobic conditions and inhibits mitochondrial respiration by
NO binding to cytochrome c oxidase of the mitochondrial electron
transport system [21]. Such an effect would be expected to modulate
oxygen consumption, possibly adjusting myocardial energetics and
mechanical performance [22]. Consistent with such a mechanism,
Rassaf and colleagues recently studied the myoglobin knock-out
mouse and reported that nitrite-dependent NO formation in the heart,
negative inotropic effects, and in vivo inhibition of mitochondrial ATP
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[22]. We have now carefully evaluated the potency of nitrite in the
heart as a negative inotrope and ﬁnd that in rat heart physiological
concentrations of nitrite as low as 1 nM elicit negative inotropy. In
particular, we show that the inotropic effect is exerted by a
mechanism involving eNOS-independent formation of NO, the
generation of iron-nitrosylated myoglobin and activation of cGMP–
PKG-pathway. This study suggests that in the beating heart nitrite is a
signiﬁcant physiological source of NO that modulates cardiac
performance. These studies compliment our growing understanding
of the role of nitrite as a vasodilator.
2. Materials and methods
2.1. Chemicals
All chemicals/drugs were purchased from Sigma unless otherwise
indicated and prepared immediately before each experiment.
2.2. Animals
Male Wistar rats (Morini, Bologna, Italy S.p.A.), weighing 180–
250 g, were housed three per cage in a ventilated cage rack system and
were fed ad libitum.
The animals were treated in accordancewith the Guide for the Care
and Use of Laboratory Animals published by the US National Institutes
of Health.
2.3. Langendorff preparation
Rats were anaesthetized with ethyl carbamate (2 g/kg rat, i.p.),
and the hearts rapidly excised and transferred in ice-cold buffered
Krebs–Henseleit solution (KHs). The aorta was immediately
cannulated with a glass cannula and connected with the Langen-
dorff apparatus to start perfusion at a constant ﬂow-rate of 12 ml/
min as previously described [23]. To avoid ﬂuid accumulation, the
apex of the left ventricle (LV) was pierced. A water-ﬁlled latex
balloon, connected to a BLPR gauge (WPI, Inc. USA), was inserted
through the mitral valve into the LV to allow isovolemic contrac-
tions and to continuously record mechanical parameters. Coronary
pressure was recorded using another pressure transducer placed
just above the aorta. Hemodynamic parameters were assessed
using a PowerLab data acquisition system and analyzed using chart
software (ADInstruments, Basile, Italy).
2.4. Experimental protocol
The Langendorff-perfused paced rat heart performance was
evaluated by analyzing the left ventricular pressure (LVP), which is
an index of contractile activity, the rate-pressure product (RPP) (as an
index of cardiac work) [24], the maximal values of the ﬁrst derivative
of LVP [+(LVdP/dt)max] which indicates the maximal rate of left
ventricular contraction, the time to peak tension of isometric twitch
(Ttp) for inotropic effect and the maximal rate of left ventricular
pressure decline of LVP [−(LVdP/dt)max], the half time relaxation
(HTR), and T/−t ratio obtained by +(LVdP/dt)max/−(LVdP/dt)max
for lusitropic effects [25]. The mean coronary pressure was calculated
as the average of values obtained during several cardiac cycles [23].Table 1
Baseline cardiac parameters in Langendorff rat heart model
Left ventricular
pressure
Heart rate Rate pressure product Coronary
pressure
L
89±2.8 mm Hg 281±7 beats/min 2.5±0.2 104 mm Hg beats/min 62±3.1 mm Hg 2The response of the hearts to pharmacological agents (L-arginine,
SNP, SNAP, GSNO, SIN-1, SOD, L-NMMA, L-NIO, C-PTIO, PTIO, Hb, ODQ,
KT5823, RT 8-Br-cGMPs and 8-Br-cGMP) was obtained by perfusing
the cardiac preparations with the buffer containing the speciﬁed
pharmacologic agent at the desired concentration in the presence or
absence of increasing concentrations of sodium nitrite.
2.5. Nitrite-dependent modiﬁcation of cardiac proteins
To measure nitrite-dependent protein modiﬁcations, perfused
hearts were frozen and homogenized in a solution of N-ethylmalei-
mide (20 mM), Nonidet P-40, and diethylenetriaminepentaacetic acid
(100 μM). Nitrite levels were determined by directly injecting these
samples into a solution of acidiﬁed tri-iodide, purging with helium in-
line with a gas-phase chemiluminescence NO analyzer (Sievers,
Boulder, CO). To determine the levels of speciﬁc NO adducts (iron–
nitrosyl–hemoglobin and S-nitrosohemoglobin) samples were
reacted with acidiﬁed sulfanilamide (0.5% v/v) to eliminate nitrite,
and mercuric chloride (5 mM), to eliminate S-nitrosothiols, before
being subjected to reductive chemiluminescence.
2.6. Statistics
Data were expressed as the mean±SEM. Since each heart
represents its own control, the statistical signiﬁcance of differences
within-group was assessed using the paired Student's t-test (Pb0.05).
Comparison between groups was made using a two-way analysis of
variance (ANOVA) followed by Duncan's test. Differences were
considered to be statistically signiﬁcant for Pb0.05.
3. Results
3.1. Nitrite potently modulates inotropy
In order to assess the effects of nitrite on cardiac function the well-
characterized Langendorff perfused rat heart model was used. Basal
parameters of this preparation are shown in Table 1 and performance
variablesmeasured every 10min showed that the heart is stable for up
to 180 min (see Fig. 1C).
Exposure of the perfused heart to nitrite (10 nM) had a signiﬁcant
negative inotropic effect on the rat heart characterized by a decrease
in LVP. The effects of nitrite reached a maximum at 5 min after initial
exposure and remained stable for up to 15 min, after which they
gradually decreased with time (see Fig. 1B).
Since repeated exposures of the heart to the same concentration of
nitrite did not result in pharmacological tolerance in control
experiments (data not shown), a cumulative dose response was
performed in the rat heart preparation. The nitrite-dependent
inotropic effect was concentration-dependent and we showed a
signiﬁcant (20%) decrease in LVP at nitrite concentrations as low as
1 nM (Fig. 1A and D). This decrease in LVP was followed by an increase
in coronary pressure, which became signiﬁcant only at higher
concentrations of nitrite (Fig. 1E).
3.2. Nitrite-induced inotropy and lusitropy in rat heart
To determine both inotropic and lusitropic effects of nitrite, the





491±128 mm Hg/s 1663±70 mm Hg/s 0.08±0.02 s 0.05±0.01 s −1.48±1.85
Fig. 1. Nitrite modulates cardiac inotropy. (A) Bar graph showing the dose–response nitrite effect on LVP (n=7). (B) Representative LVP trace showing the effect of single
concentration of nitrite (10−8M). (C) Representative LVP trace showing the time course obtained in the presence of vehicle alone. (D) Representative LVP trace showing the effects of
increasing concentrations (10−10 to 10−4 M) of nitrite (each arrow represents the administration of a single concentration). (E) Representative CP trace showing the effects of
increasing concentrations (10−10 to 10−4 M) of nitrite (each arrow represents the administration of a single concentration). Percentage changes were evaluated as means±S.E.M.
Asterisks indicate values signiﬁcantly different from the control value: ⁎Pb0.05, ⁎⁎Pb0.025, ⁎⁎⁎Pb0.01.
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Nitrite mediated negative inotropic and lusitropic responses as
demonstrated by a signiﬁcant decrease in LVP, RPP, +(LVdP/dt)max,
and−(LVdP/dt)max, in parallel with a signiﬁcant increase in T/−t. A
small, but signiﬁcant decrease in HTR was also observed when nitrite
concentration reached 100 μM (Fig. 2). Taken together, these data
suggest that physiological concentrations of nitrite mediate negative
inotropy and lusitropy even at basal conditions (i.e. perfusion with
normoxic buffer).
3.3. A comparison of nitrite-dependent negative inotropic effects with
other NO donors suggests an NO-dependent mechanism of activity
A number of studies have shown that nitrite mediates its effects
through its conversion to NO. Hence, we compared the inotropic
effects of nitrite and authentic NO. To determine the effects of
endogenously NO synthase (NOS)-generated NO on cardiac function,
we treated the isolated heart preparations with the physiological
substrate for NOS, L-arginine. Routinely [26], we use L-lysine as an
amino acid control instead of D-arginine because, as stated by Amrani
et al. [27], the latter is not taken up by amino acid uptake mechanism
and therefore cannot be used as a control. L-arginine (10−8 M)
induced a signiﬁcant decrease in LVP (−17%), similar to the effectsFig. 2. Nitrite modulates lusitropic parameters. Cumulative dose–response curves showing
(n=7). Percentage changes were evaluated as means±S.E.M. Asterisks indicate values signobserved with nitrite. The L-arginine-dependent effect was inhibited
by the NOS inhibitor L-NMMA (10 μM), conﬁrming that the inotropic
effects of L-arginine were indeed NOS-dependent (see Fig. 3A). These
data suggest that NOS-derived NO has a similar negative inotropic
effect as nitrite-derived NO.
We then tested the effects of the NOS-independent NO donors,
sodium nitroprusside (SNP) (0.1 nM to 100 μM), S-nitrosoglutathione
(GSNO) (0.1 nM to 100 μM), and S-nitrosopenacillamine (SNAP)
(0.1 nM to 100 μM), as well as SIN-1 (0.1 nM to 100 μM), a
simultaneous donor of NO and superoxide (O2−) (Fig. 3A and B).
Similar to nitrite, SNP, which is a direct NO donor, was a negative
inotrope, mediating a decrease in LVP at nanomolar concentrations.
In contrast, GSNO, SNAP and SIN-1 exerted a biphasic effect, with
low concentrations (0.1–1 nM) resulting in a signiﬁcant (20%)
increase in LVP and higher concentrations resulting in a decrease in
LVP and (LVdP/dt)max (Fig. 3A and B). It is of physiological interest
that in rat isolated hearts GSNO, generated by a nitrosative pathway,
was shown to activate sGC through Cu2+-catalysed release of free NO
[28]. When SIN-1 is converted to a pure NO donor by the removal of
superoxide with superoxide dismutase, the drug exhibited negative
inotropy even at a lower concentration (10−10 M) (Fig. 3D), consistent
with the observed effects of L-arginine and SNP and effects reported
by Paolocci et al. [16].nitrite effect on inotropic and lusitropic parameters in isolated and perfused rat hearts
iﬁcantly different from the control value: ⁎Pb0.05, ⁎⁎Pb0.025, ⁎⁎⁎Pb0.01.
Fig. 3. Endogenously produced NOmodulates cardiac inotropy. (A, B) The effect of NO donors on isolated and perfused rat hearts (n=5–7). On the right the effect of the authentic NO
donor L-arginine (10−8 M) is depicted (n=4) (C) Representative LVP and CP traces showing the effects of GSNO (10−9 M) on isolated and perfused rat hearts. (D) Effect of SIN-1
(10−10 M) on isolated and perfused rat hearts before and after treatment with SOD (10 IU/ml) (n=4–5 for each group). Percentage changes were evaluated as means±S.E.M.
Asterisks indicate values signiﬁcantly different from the control value: ⁎Pb0.05, ⁎⁎Pb0.025, ⁎⁎⁎Pb0.01.
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from that of nitrite, L-arginine, SNP, and SIN-1 with SOD, showing a
biphasic response similar to SIN-1 without SOD. This differential effect
could be secondary to unique effects of nitrosonium NO donors or
secondary to potent coronary perfusion effects that modulate
inotropy. A typical coronary dilation trace elicited by GSNO is shown
in Fig. 3C.
These data demonstrate that in this system, NO generated by a
number of sources (both endogenous and exogenous) and nitrite
behave similarly. The divergent effects of GSNO, compared with
nitrite, L-arginine, SIN-1 with SOD, and SNP, suggest that nitrite does
not behave in the heart as an S-nitrosothiol donor, but as a direct NO
radical donor.
3.4. Nitrite-dependent negative inotropy is NO-dependent but NOS
independent
Since NO and nitrite mediate similar effects on the heart, we
investigated whether NOS was involved in the negative inotropic
effect of nitrite. To determine whether nitrite may be stimulating NO
production from NOS or whether NOS reduces nitrite to NO as
previously reported [5], we exposed the isolated rat heart to nitrite
(0.1 nM–100 μM) in the presence and absence of the NOS inhibitors L-
NMMA or L-NIO (Fig 4A and B).
Treatment with L-NMMA (0.1 nM–100 μM) did not modify the
nitrite-induced decrease in LVP and +(LVdP/dt)max (Fig. 4A).
Although the selective inhibition of eNOS by L-NIO (0.1 nM–
100 μM) appears to enhance the nitrite-dependent decrease in LVP,
this can be accounted for by the decrease in LVP observed in the
presence of L-NIO alone (Fig. 4A).
To test whether the reduction of nitrite to NO is involved in the
mechanism of nitrite-dependent negative inotropy, rat hearts were
treated with nitrite in the presence and absence of the NO scavengersFig. 4.Nitrite-dependent negative inotropy is NO-dependent. (A, B) The effect of nitrite of LVP
(C, D) The effect of nitrite alone and in the presence of C-PTIO (10−7 M), PTIO (10−7 M) anC-PTIO (100 nM), PTIO (100 nM), or oxyhemoglobin (10 μM) (Fig. 4C
and D). In this system the heart is perfused with oxygenated buffer
and hence hemoglobin will remain oxygenated to react with and
inactivate NO but will not reduce nitrite to NO. The nitrite-dependent
decrease in LVP and +(LVdP/dT)max was signiﬁcantly attenuated by
all three NO scavengers suggesting that NO formation from nitrite
mediates the negative inotropic effects.
The response of the hearts to pharmacological agents (L-NMMA, L-
NIO, C-PTIO, PTIO, Hb) was obtained by perfusing the cardiac
preparations with the buffer containing the speciﬁed pharmacologic
agent at the desired concentration in the presence or absence of
increasing concentrations of sodium nitrite. Under basal conditions,
the LVP value was 4.94±1.83% in the presence of L-NMMA alone;
5.10±2.47% in the presence of L-NIO alone; −5.98±3.04% in the
presence of C-PTIO alone; −4.65±3.71% in the presence of PTIO
alone; 4.81±2.5% in the presence of Hb alone. However, these
variations were not signiﬁcantly different from the control values and
did not affect the analysis of effect on nitrite signalling.
3.5. Nitrite-dependent formation of cardiomyocyte iron-nitrosylated
hemoproteins (Fe+2-NO)
Since nitrite-dependent negative inotropy appears to be NO
mediated, but not dependent on NOS, we hypothesized that nitrite
is reduced to NO by hemoproteins in the heart. While several
mechanisms of nitrite reduction have previously been described, we
and others have previously shown that myoglobin is the predominant
nitrite reductase in the rat and mouse hearts [21,22]. However, other
investigators have reported a role of XOR in the heart as a nitrite
reductase [14]. The balance of data suggests that both pathways
contribute to NO formation from nitrite in the heart. Reduction of
nitrite by myoglobin and the concomitant NO production from this
reaction has been correlated with an increase in the concentration ofand LVdP/dt max alone and in the presence of L-NMMA (10−5 M) and L-NIO (10−5 M).
d Hb (10−5 M) on LVP and LVdP/dt max in isolated and perfused rat hearts.
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nitrite is reduced by hemoproteins in the perfused heart, levels of
iron–nitrosyl and S-nitrosated proteins were measured by reductive
chemiluminescence in perfused, paced rat hearts after treatment with
either nitrite (0.1 nM–10 μM) or saline (Fig. 5).
As expected, nitrite-treated hearts contained higher concentra-
tions of nitrite (187±16 pmol/mg) than control hearts (50±
22 pmol/mg) (Fig. 5A – C). Hearts treated with nitrite also had
signiﬁcantly higher concentrations of S-nitrosothiols (103±
17 pmol/mg) (Fig. 5D) and iron-nitrosylated proteins (165±
19 pmol/mg) (Fig. 5D) in comparison to control hearts (1.8±0.8
and 0.7±0.1 pmol/mg respectively). These data are consistent
with the reduction of nitrite to NO by heme containing proteins,
most probably myoglobin and xanthine oxidoreductase, in the
heart.
3.6. Nitrite mediates negative inotropy through activation of sGC
Several studies have shown that activation of the NO–sGC pathway
can mediate negative inotropy in the mammalian heart [27,39]. To
determine whether this is the mechanism of nitrite-dependent
negative inotropy, hearts were treated with ODQ (0.1 nM–100 μM),
a potent oxidant and soluble guanylate cyclase inhibitor, and thenFig. 5. Nitrite perfusion generates S-nitrosothiol and iron–nitrosyl in the heart. Rat hearts w
chemiluminescence. (A, B) Representative raw trace of saline (A) and nitrite (B) perfused he
treatment with acidiﬁed sulfanilamide (AS) and acidiﬁed sulfanilamide and mercuric chlori
such as those in panels A and B. Data are means±SEM of at least 5 independent hearts.subjected to nitrite treatment. While ODQ treatment signiﬁcantly
attenuated the negative inotropic effect of nitrite (Fig. 6A and B), it
remains possible that ODQ will also oxidize heme proteins necessary
for nitrite reduction. Therefore to further test a role for the cGMP
pathway we inhibited protein kinase G (PKG). PKG is a downstream
target of sGC and cGMP. Inhibition of PKG by KT5823 (100 nM)
abolished nitrite-dependent negative inotropy supporting the invol-
vement of the NO–sGC pathway (Fig. 6C and D). Inhibition of the
nitrite-dependent negative inotropic effect by Rp-8-Br-cGMPs,
another speciﬁc inhibitor of PKG, conﬁrmed the involvement of PKG
in the mechanism of nitrite's actions (Fig. 6C and D). In addition, we
have tested the effects of the cGMP analogue 8-Br-cGMP in the
presence and absence of the speciﬁc PKG inhibitors, KT5823 and Rp-8-
Br-cGMPs. These data show that 8-Br-cGMP induces a dose-depen-
dent negative inotropism which is abolished in presence of both PKG
inhibitors (Fig. 6E and F).
Under basal conditions, the LVP value was −4.99±2.64% in the
presence of ODQ alone; 2.48±1.77% in the presence of KT5823 alone;
−2.08±1.68% in the presence of Rp-8-Br-cGMPs alone. However,
these variations were not signiﬁcantly different from the control
values.
Taken together, these data demonstrate that nitrite-dependent
negative inotropy is dependent on the formation of NO, but independentere perfused with either nitrite (10−10 to 10−4 M) or saline and tissue was analyzed by
art subjected to tri-iodide based chemiluminescence with no pretreatment (untreated),
de (Hg + AS). (C–E) Quantiﬁcation of nitrite (C), S-NO (D), and Fe-NO (E) from traces
Fig. 6. Nitrite-dependent negative inotropy is cGMP–PKG-dependent. The effect of nitrite alone and in the presence of ODQ (10−5 M) (A, B) or KT5823 (10−7 M) or Rp-8-Br-
cGMPs (10−7 M) (C, D) and the effect of 8-Br-cGMP alone and in the presence of KT5823 (10−7 M) or Rp-8-Br-cGMPs (10−7 M) (E, F) on inotropic parameters in isolated and
perfused rat hearts (n=5–7). Percentage changes were evaluated as means±S.E.M. Asterisk indicates values signiﬁcantly different from the control value: ⁎Pb0.05, ⁎⁎Pb0.025,
⁎⁎⁎Pb0.01.
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guanylate cyclase–PKG cascade.
4. Discussion
In this study, we have shown that physiological concentrations of
nitrite potently affect cardiac mechanical performance by modulating
contractility in the beating heart. In fact, nitrite elicited a concentra-
tion-dependent negative inotropic and lusitropic effects, decreasing
LVP and (LVdP/dt)max. Furthermore, we show that the nitrite-
dependent negative inotropic effect parallels the effects of authentic
NO in this system and is inhibited by NO scavengers but not NO
synthase inhibition, suggesting that nitrite is reduced to NO in the
beating heart via NOS-independent mechanisms. Mechanistically, we
show evidence that this negative inotropic effect is mediated via
activation of the NO–sGC–PKG pathway.
In the rat Langendorff heart, after more than an hour of activity the
heart gradually develops coronary constriction. However, the nitrite-
dependent negative inotropy clearly precedes this increased vaso-pressure response demonstrating that nitrite-elicited inotropy is
independent from other vascular effects of the anion. In another
study using avascular endoluminally perfused hearts of ﬁsh (Anguilla
anguilla) and frog (Rana esculenta), we showed similar nitrite-induced
negative inotropic effects thus consistent with direct myocardial (and
coronary-independent) action [29].
Several studies have demonstrated an NO–cGMP-dependent
negative inotropy in the mammalian heart [16,30–32]. While NOS
has previously been considered as the physiological source of NO in
these studies, here we show that physiological stores of nitrite, which
exist in both blood (150–300 nM) [33] and tissue (0.5–2 μM) [34],
may also be an integral source of NO. This thesis is supported by the
observed high potency of nitrite with signiﬁcant effects on inotropy
observed at concentrations (1 nM) well below the physiological level.
The effects of nitrite on inotropy cannot be inhibited by NO synthase
blockers. The effects are inhibited by direct NO scavenging by PTIO and
oxyhemoglobin, as well as by inhibition of the NO–cGMP–PKG
pathway. These data support an emerging paradigm that nitrite
subserves a function as a NOS independent source of NO [35].
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suggest an NO-dependent effect of nitrite on cardiac inotropy.
Accordingly, L-arginine increases NO formation from NOS and exerts
similar negative inotropic effects as nitrite. The direct NO donors
sodium nitroprusside and SIN-1, treated with SOD to scavenge the
superoxide, both exert negative inotropy. Note that SOD treatment of
SIN-1 converts this donor to an NO donor [36]. The biological response
to S-nitrosothiol NO donors appears to be unique from that of nitrite,
L-arginine, SNP, and SIN-1 with SOD, since S-nitrosothiol NO donors
show a biphasic response similar to SIN-1 without SOD. This
differential effect could be secondary to unique effects of nitrosonium
NO donors or secondary to potent coronary perfusion effects that
modulate inotropy. The comparative NO donor experimental data
demonstrate that, in this system, NO generated by a number of sources
(both endogenous and exogenous) and nitrite behave similarly. The
divergent effects of GSNO, compared with nitrite, L-arginine, SIN-1
with SOD, and SNP, suggest that nitrite does not behave in the heart as
an S-nitrosothiol donor, but as a direct NO radical donor.
The inhibition of the nitrite-dependent decrease in LVP in the
presence of ODQ suggests the involvement of the soluble guanylate
cyclase–cGMP in this mechanism. An important intramyocardial
target of cGMP is a cGMP-dependent protein kinase (PKG). The
ﬁnding that KT5823, an inhibitor structurally unrelated to cGMP,
abolished the nitrite-induced inotropy is consistent with a cGMP–
PKG-dependent mechanism underlying the nitrite-induced negative
inotropy. In fact, it is well acknowledged that in many tissues,
including rat ventricular myocytes, NO, by targeting soluble GC, and
thus PKG, negatively affects contractility by reducing L-type Ca2+
current [37,38] and by phosphorylating troponin I, thus reducing
troponin C afﬁnity for calcium, and depressing contractility [39].
Conceivably, both L-type Ca2+ current reduction and PKG-mediated
myoﬁlament desensitization to Ca2+ may account for this nitrite-
induced negative inotropy (see [39] for reference).
Several mechanisms by which nitrite can be reduced to NO along
a physiological oxygen and pH gradient have previously been
described. In this study, by using a hemoglobin-free perfusate and
NOS inhibitors, we have demonstrated that hemoglobin and NOS are
not involved in nitrite reduction in the myocardial tissue perfused
with buffer. We have previously shown that myoglobin is the
predominant nitrite reductase in the hypoxic heart, and that NO
generation from myoglobin can bind to and inhibit cytochrome c
oxidase of the mitochondrial electron transport chain to inhibit
cellular respiration [21,22]. Indeed it has also been shown that
during hypoxia, myoglobin-dependent reduction of nitrite to NO in
the heart is responsible for the downregulation of cardiac energy
status [22]. Interestingly, in this study, even though the heart was
perfused with normoxic buffer, an increase in iron–nitrosyl heme in
the nitrite-infused heart tissue was detected, consistent with
myoglobin-dependent nitrite reduction. This suggests that in the
heart even with adequate oxygen supply, tissue oxygen concentra-
tion and/or pH falls low enough to deoxygenate myoglobin and
allow the reduction of nitrite to occur. In fact, in the mammalian
heart, the presence of a signiﬁcant transmural oxygen gradient has
been reported. For example, in the dog heart, characterized by an
abundant collateral coronary circulation and in which the myocar-
dial pO2 averages around 31 mm Hg, the transmural oxygen gradient
is 15–20 mm Hg, the lowest pO2 values being detected in the
innermost myocardial layers (subendocardium) [40]. This situation
can be even more exacerbated in those hearts such as the human,
pig and rat hearts which are supplied by a terminal type of coronary
arterial vascularization.
In our study, nitrite dose-dependently decreases oxygen con-
sumption in the rat heart (data not shown). A negative inotropism,
accompanied by a decreased myocardial oxygen consumption, has
been recently reported in a Langendorff perfused mice heart [22].
Interestingly, these effects, obtained only at higher concentrations(100 μM/L) than the present study, were not observed in Mb-lacking
mice [22].
In conclusion, we have shown that nitrite mediates negative
inotropy in the rat heart through a mechanism involving its reduction
to NO and consequent cGMP–PKG-dependent modulation of contrac-
tility. Although the exact target of nitrite is unknown, it is clear that
even during normoxic conditions, nitrite is an important source of NO
in the beating heart. This study may have implications for under-
standing themechanisms bywhich nitrite regulates cardiac energetics
physiologically and protect the heart during pathological ischemia.References
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